Congratulations to Dr. Lynes for receiving a highly competitive UConn SPARK Technology Commercialization Fund Program award for his work on Anti-metallothionein antibody: a safe and effective anti-inflammatory therapy!

Posted on by

The UConn SPARK Technology Commercialization Fund provides that invaluable initial support to move technologies along the innovation continuum so they can more quickly and successfully reach the market, benefit society, and impact economic growth in Connecticut.

View full article here.